Fate Therapeutics

Filed a patent for "solid tumor targeting backbone promoting effector cell differentiation and function" on Wed, August 2, 2023

Filed a patent for "ipsc-derived nk cell for lymphoma treatment" on Fri, April 7, 2023

Filed a patent for "effector cells and use thereof for allogeneic adoptive cell therapies in solid tumors" on Thu, April 18, 2024

Filed a patent for "compositions and methods for immune cell modulation in adoptive immunotherapies" on Thu, August 8, 2024

Filed a patent for "enhancing effector cell durability and efficacy in adoptive cell therapies" on Fri, July 1, 2022

Filed a patent for "methods and compositions for inducing hematopoietic cell differentiation" on Wed, September 14, 2022

Filed a patent for "cells having solid tumor targeting backbone and use thereof" on Thu, October 20, 2022

Filed a patent for "off-the-shelf therapeutic cells with multiplex genomic engineering for targeting kallikrein-2" on Tue, November 1, 2022

Filed a patent for "off-the-shelf therapeutic cells with multiplex genomic engineering for targeting gprc5d" on Wed, November 2, 2022

Filed a patent for "off-the-shelf therapeutic cells with multiplex genomic engineering for targeting cd79b" on Wed, November 2, 2022

Filed a patent for "ipsc-derived nk cell targeting mica/b for solid tumor treatment" on Mon, November 7, 2022

Filed a patent for "stealth strategy engaging immune recognition pathways for use in allogeneic cell therapies" on Mon, November 7, 2022

Filed a patent for "off-the-shelf therapeutic cells with multiplex genomic engineering for targeting gprc5d" on Wed, November 30, 2022

Filed a patent for "stealth strategy engaging immune recognition pathways for use in allogeneic cell therapies" on Fri, December 9, 2022

Filed a patent for "combining ipsc derived effector cell types for immunotherapy use" on Thu, July 27, 2023

Filed a patent for "methods and compositions for inducing hematopoietic cell differentiation" on Thu, July 6, 2023

Filed a patent for "improved reprogramming, maintenance and preservation for induced pluripotent stem cells" on Thu, February 1, 2024

Filed a patent for "engineered ipsc and armed immune effector cells" on Thu, February 1, 2024

Filed a patent for "multiplexed engineered ipscs and immune effector cells targeting solid tumors" on Thu, November 30, 2023

Filed a patent for "engineered ipsc and immune effector cells for heterogenous tumor control" on Thu, December 21, 2023

Filed a patent for "engineered ipsc and persistent immune effector cells" on Thu, December 7, 2023

Filed a patent for "off-the-shelf ipsc-derived nk cell therapy for hematological cancer treatment" on Thu, March 28, 2024

Filed a patent for "chimeric antigen receptor for tumor targeting" on Thu, January 4, 2024

Filed a patent for "cells having solid tumor targeting backbone and use thereof" on Thu, November 9, 2023

Filed a patent for "composition and methods for inducing myeloid suppressive cells and use thereof" on Thu, May 16, 2024